Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

Vincenzo La Mura, Juan Carlos Reverter, Alexandra Flores-Arroyo, Sebastián Raffa, Enric Reverter, Susana Seijo, Juan G. Abraldes, Jaime Bosch, Juan Carlos García-Pagán

Research output: Contribution to journalArticle

Abstract

Background and aims: Endothelial dysfunction is a major determinant of the increased hepatic vascular tone of cirrhotic livers. Von Willebrand factor (vWF), P-selectin and 8-iso-PGF2α (isoprostanes), surrogate markers of endothelial dysfunction, are increased in patients with cirrhosis. This study was aimed at exploring in patients with cirrhosis and portal hypertension the relation of these endothelial factors with systemic and hepatic haemodynamics and their possible clinical prognostic value. Methods: 42 consecutive patients with cirrhosis and portal hypertension had measurement of the hepatic venous pressure gradient (HVPG), cardiopulmonary pressures and vWF, P-selectin and isoprostane levels in blood samples from hepatic and peripheral veins. Patients were followed up to 2 years, death or liver transplantation and any clinical event were recorded. Results: vWF, P-selectin and isoprostanes were increased in patients with cirrhosis compared with controls (p

Original languageEnglish
Pages (from-to)1133-1138
Number of pages6
JournalGut
Volume60
Issue number8
DOIs
Publication statusPublished - Aug 2011

Fingerprint

von Willebrand Factor
Portal Hypertension
Fibrosis
Isoprostanes
P-Selectin
Liver
Dinoprost
Venous Pressure
Hepatic Veins
Liver Transplantation
Blood Vessels
Biomarkers
Hemodynamics
Pressure

ASJC Scopus subject areas

  • Gastroenterology

Cite this

La Mura, V., Reverter, J. C., Flores-Arroyo, A., Raffa, S., Reverter, E., Seijo, S., ... García-Pagán, J. C. (2011). Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. Gut, 60(8), 1133-1138. https://doi.org/10.1136/gut.2010.235689

Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. / La Mura, Vincenzo; Reverter, Juan Carlos; Flores-Arroyo, Alexandra; Raffa, Sebastián; Reverter, Enric; Seijo, Susana; Abraldes, Juan G.; Bosch, Jaime; García-Pagán, Juan Carlos.

In: Gut, Vol. 60, No. 8, 08.2011, p. 1133-1138.

Research output: Contribution to journalArticle

La Mura, V, Reverter, JC, Flores-Arroyo, A, Raffa, S, Reverter, E, Seijo, S, Abraldes, JG, Bosch, J & García-Pagán, JC 2011, 'Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension', Gut, vol. 60, no. 8, pp. 1133-1138. https://doi.org/10.1136/gut.2010.235689
La Mura, Vincenzo ; Reverter, Juan Carlos ; Flores-Arroyo, Alexandra ; Raffa, Sebastián ; Reverter, Enric ; Seijo, Susana ; Abraldes, Juan G. ; Bosch, Jaime ; García-Pagán, Juan Carlos. / Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. In: Gut. 2011 ; Vol. 60, No. 8. pp. 1133-1138.
@article{e47d0ccb89364a7eae5178d29bf465a4,
title = "Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension",
abstract = "Background and aims: Endothelial dysfunction is a major determinant of the increased hepatic vascular tone of cirrhotic livers. Von Willebrand factor (vWF), P-selectin and 8-iso-PGF2α (isoprostanes), surrogate markers of endothelial dysfunction, are increased in patients with cirrhosis. This study was aimed at exploring in patients with cirrhosis and portal hypertension the relation of these endothelial factors with systemic and hepatic haemodynamics and their possible clinical prognostic value. Methods: 42 consecutive patients with cirrhosis and portal hypertension had measurement of the hepatic venous pressure gradient (HVPG), cardiopulmonary pressures and vWF, P-selectin and isoprostane levels in blood samples from hepatic and peripheral veins. Patients were followed up to 2 years, death or liver transplantation and any clinical event were recorded. Results: vWF, P-selectin and isoprostanes were increased in patients with cirrhosis compared with controls (p",
author = "{La Mura}, Vincenzo and Reverter, {Juan Carlos} and Alexandra Flores-Arroyo and Sebasti{\'a}n Raffa and Enric Reverter and Susana Seijo and Abraldes, {Juan G.} and Jaime Bosch and Garc{\'i}a-Pag{\'a}n, {Juan Carlos}",
year = "2011",
month = "8",
doi = "10.1136/gut.2010.235689",
language = "English",
volume = "60",
pages = "1133--1138",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

AU - La Mura, Vincenzo

AU - Reverter, Juan Carlos

AU - Flores-Arroyo, Alexandra

AU - Raffa, Sebastián

AU - Reverter, Enric

AU - Seijo, Susana

AU - Abraldes, Juan G.

AU - Bosch, Jaime

AU - García-Pagán, Juan Carlos

PY - 2011/8

Y1 - 2011/8

N2 - Background and aims: Endothelial dysfunction is a major determinant of the increased hepatic vascular tone of cirrhotic livers. Von Willebrand factor (vWF), P-selectin and 8-iso-PGF2α (isoprostanes), surrogate markers of endothelial dysfunction, are increased in patients with cirrhosis. This study was aimed at exploring in patients with cirrhosis and portal hypertension the relation of these endothelial factors with systemic and hepatic haemodynamics and their possible clinical prognostic value. Methods: 42 consecutive patients with cirrhosis and portal hypertension had measurement of the hepatic venous pressure gradient (HVPG), cardiopulmonary pressures and vWF, P-selectin and isoprostane levels in blood samples from hepatic and peripheral veins. Patients were followed up to 2 years, death or liver transplantation and any clinical event were recorded. Results: vWF, P-selectin and isoprostanes were increased in patients with cirrhosis compared with controls (p

AB - Background and aims: Endothelial dysfunction is a major determinant of the increased hepatic vascular tone of cirrhotic livers. Von Willebrand factor (vWF), P-selectin and 8-iso-PGF2α (isoprostanes), surrogate markers of endothelial dysfunction, are increased in patients with cirrhosis. This study was aimed at exploring in patients with cirrhosis and portal hypertension the relation of these endothelial factors with systemic and hepatic haemodynamics and their possible clinical prognostic value. Methods: 42 consecutive patients with cirrhosis and portal hypertension had measurement of the hepatic venous pressure gradient (HVPG), cardiopulmonary pressures and vWF, P-selectin and isoprostane levels in blood samples from hepatic and peripheral veins. Patients were followed up to 2 years, death or liver transplantation and any clinical event were recorded. Results: vWF, P-selectin and isoprostanes were increased in patients with cirrhosis compared with controls (p

UR - http://www.scopus.com/inward/record.url?scp=79960322140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960322140&partnerID=8YFLogxK

U2 - 10.1136/gut.2010.235689

DO - 10.1136/gut.2010.235689

M3 - Article

C2 - 21427197

AN - SCOPUS:79960322140

VL - 60

SP - 1133

EP - 1138

JO - Gut

JF - Gut

SN - 0017-5749

IS - 8

ER -